These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3009051)

  • 1. Prevalence of antibodies to HTLV-III in quality-assurance sera.
    Howanitz PJ; McBride JH; Kliewer KE; Rodgerson DO
    Clin Chem; 1986 May; 32(5):773-7. PubMed ID: 3009051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of HTLV-III antibodies in immune serum globulin preparations.
    Lai-Goldman M; McBride JH; Howanitz PJ; Rodgerson DO; Miles JA; Peter JB
    Am J Clin Pathol; 1987 May; 87(5):635-9. PubMed ID: 3554975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of specimen treatment on nonreactive HTLV-III sera.
    McBride JH; Howanitz PJ; Rodgerson DO; Miles J; Peter JB
    AIDS Res Hum Retroviruses; 1987; 3(3):333-40. PubMed ID: 3325086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
    Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunoglobulin G capture assay (GACRIA) for anti-HTLV III/LAV and its use as a confirmatory test.
    Parry JV
    J Med Virol; 1986 Aug; 19(4):387-97. PubMed ID: 3018141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of the Abbott HTLV III EIA, a test for antibody to HTLV III in donor blood.
    Barrett JE; Dawson G; Heller J; Bairstow C; Fico R; Webber JS; Gutierrez R; Decker RH
    Am J Clin Pathol; 1986 Aug; 86(2):180-5. PubMed ID: 3017089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
    Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of enzyme immunoassay tests for detection of HTLV-III/LAV antibodies.
    Lyons SF; McGillivray GM; Coppin AP; Schoub BD
    S Afr Med J; 1985 Oct; 68(8):575-6. PubMed ID: 2996159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East Africa.
    Biggar RJ; Johnson BK; Oster C; Sarin PS; Ocheng D; Tukei P; Nsanze H; Alexander S; Bodner AJ; Siongok TA
    Int J Cancer; 1985 Jun; 35(6):763-7. PubMed ID: 2989191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of 3 immuno-enzyme kits for the detection of anti-LAV antibodies. Comparison with confirmation tests. Study Subgroup of the National Blood Transfusion Society].
    Rev Fr Transfus Immunohematol; 1985 Sep; 28(4):325-44. PubMed ID: 3001897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HTLV-III testing of blood donors: reproducibility and confirmability of commercial test kits.
    Holland PV; Richards CA; Teghtmeyer JR; Douville CM; Carlson JR; Hinrichs SH; Pedersen NC
    Transfusion; 1985; 25(4):395-7. PubMed ID: 2992129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased reactivity to HTLV-I in inflammatory nervous system diseases.
    Lolli F; Fredrikson S; Kam-Hansen S; Link H
    Ann Neurol; 1987 Jul; 22(1):67-71. PubMed ID: 2888429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural antibodies in sera from Japanese individuals infected with HTLV-I do not recognize HTLV-III.
    Hattori T; Robert-Guroff M; Chosa T; Matsuoka M; Yamaguchi K; Ishii T; Gallo RC; Takatsuki K
    Blood; 1985 Sep; 66(3):745-7. PubMed ID: 2992645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS.
    Chang NT; Huang J; Ghrayeb J; McKinney S; Chanda PK; Chang TW; Putney S; Sarngadharan MG; Wong-Staal F; Gallo RC
    Nature; 1985 May 9-15; 315(6015):151-4. PubMed ID: 2986016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-III/LAV infection in hemodialysis patients.
    Peterman TA; Lang GR; Mikos NJ; Solomon SL; Schable CA; Feorino PM; Britz JA; Allen JR
    JAMA; 1986 May; 255(17):2324-6. PubMed ID: 3007792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies to human T-lymphotropic virus type 1 (HTLV-1).
    Fang CT; Williams AE; Sandler SG; Slamon DJ; Poiesz BJ
    Transfusion; 1988; 28(2):179-83. PubMed ID: 2832983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
    Abb J
    AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-cell lymphotropic virus type I infection in neonates.
    Hara T; Takahashi Y; Sonoda S; Kusuhara K; Ueda K
    Am J Dis Child; 1987 Jul; 141(7):764-5. PubMed ID: 2884867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of HTLV-III antibodies using ELISA and the western blot].
    Kunz C; Heinz FX
    Wien Klin Wochenschr; 1985 Nov; 97(22):829-32. PubMed ID: 3002046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.